Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Using gastroprotectants to combat aspirin-related gastrointestinal bleeding

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.20
Views: 154

Prof Angel Lanas - University of Zaragoza, Zaragoza, Spain

Prof Angel Lanas speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about increasing the use of gastroprotectant agents to combat the risk of gastrointestinal bleeding from aspirin.

He explains that in order to improve the risk benefit for people who take drugs that could damage the GI tract (such as aspirin) we need to also prescribe more gastroprotectants for patients, particularly those that are already at an increased risk.

Prof Lanas acknowledges that patients in this population are likely to be taking a number of different medications but that it doesn't shy away from the fact that the medication is still necessary to combat any gastrointestinal issues.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.

Related videos

follow us

SIOG metastatic renal cell carcinoma

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation